BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hardinger KL, Brennan DC. Novel immunosuppressive agents in kidney transplantation. World J Transplant 2013; 3(4): 68-77 [PMID: 24392311 DOI: 10.5500/wjt.v3.i4.68]
URL: https://www.wjgnet.com/2220-3230/full/v3/i4/68.htm
Number Citing Articles
1
Karly P. Garnock-Jones. Tacrolimus Prolonged Release (Envarsus®): A Review of Its Use in Kidney and Liver Transplant Recipients. Drugs 2015; 75(3) doi: 10.1007/s40265-015-0349-2
2
Haiyan Xu, Panpan Dong, Xiaozhou He, Xuyi Ma, Dong Xue, Yanyun Zhang, Xueguang Zhang. B‐cell‐activating factor code and human cytomegalovirus infection in renal transplant recipients. Microbiology and Immunology 2014; 58(8) doi: 10.1111/1348-0421.12167
3
Ching-Hsia Hung, Shih-Hung Chan, Pei-Ming Chu, Kun-Ling Tsai. Docetaxel Facilitates Endothelial Dysfunction through Oxidative Stress via Modulation of Protein Kinase C Beta: The Protective Effects of Sotrastaurin. Toxicological Sciences 2015; 145(1) doi: 10.1093/toxsci/kfv017
4
Alexander E Giakoustidis, Dimitrios E Giakoustidis. Immunosuppression Strategies in Liver Transplantation Patient; Patients with Hepatocellular Carcinoma. Immunotherapy 2017; 9(2) doi: 10.2217/imt-2016-0110
5
Bee Yean Ong, Zoriah Aziz. Efficacy of Cordyceps sinensis as an adjunctive treatment in kidney transplant patients: A systematic-review and meta-analysis. Complementary Therapies in Medicine 2017; 30 doi: 10.1016/j.ctim.2016.12.007
6
Marta Sobotková, Jiřina Bartůňková. Current trends in immunosuppressive treatment. Vnitřní lékařství 2019; 65(2) doi: 10.36290/vnl.2019.027
7
Zhila Othman, Khadija Ahmed, Dana Sharif. ORAL MANIFESTATIONS IN RENAL TRANSPLANT RECIPIENTS IN SULAIMANI CITY, KURDISTAN REGION, IRAQ. JOURNAL OF SULAIMANI MEDICAL COLLEGE 2021; 11(1) doi: 10.17656/jsmc.10291
8
Takayuki Yamamoto, Qi Li, Hidetaka Hara, Liaoran Wang, Hongmin Zhou, Juan Li, Devin E. Eckhoff, A. Joseph Tector, Edwin C. Klein, Ray Lovingood, Mohamed Ezzelarab, David Ayares, Yi Wang, David K.C. Cooper, Hayato Iwase. B cell phenotypes in baboons with pig artery patch grafts receiving conventional immunosuppressive therapy. Transplant Immunology 2018; 51 doi: 10.1016/j.trim.2018.08.005
9
Aaron M. Williams, Meredith Barrett, Abigail R. Smith, Ranganath G. Kathawate, Kenneth J. Woodside, Randall S. Sung. Variable Benefits of Antibody Induction by Kidney Allograft Type. Journal of Surgical Research 2020; 248 doi: 10.1016/j.jss.2019.11.015
10
S Tomasoni, P Trionfini, N Azzollini, L Zentilin, M Giacca, S Aiello, L Longaretti, E Cozzi, N Baldan, G Remuzzi, A Benigni. AAV9-mediated engineering of autotransplanted kidney of non-human primates. Gene Therapy 2017; 24(5) doi: 10.1038/gt.2017.21
11
Daniel Baron, Magali Giral, Sophie Brouard. Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes. Transplant International 2015; 28(8) doi: 10.1111/tri.12578
12
K.A. Thomas, N.M. Valenzuela, D. Gjertson, A. Mulder, M.C. Fishbein, G.C. Parry, S. Panicker, E.F. Reed. An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA. American Journal of Transplantation 2015; 15(8) doi: 10.1111/ajt.13273
13
Ryszard Grenda. Biologics in renal transplantation. Pediatric Nephrology 2015; 30(7) doi: 10.1007/s00467-014-2886-4
14
Hani Oweira, Ali Ramouz, Omid Ghamarnejad, Elias Khajeh, Sadeq Ali-Hasan-Al-Saegh, Rajan Nikbakhsh, Christoph Reißfelder, Nuh Rahbari, Arianeb Mehrabi, Mahmoud Sadeghi. Risk Factors of Rejection in Renal Transplant Recipients: A Narrative Review. Journal of Clinical Medicine 2022; 11(5) doi: 10.3390/jcm11051392
15
Johann Castañeda-Sanabria, David Hajage, Melisande Le Jouan, Anne Perozziello, Florence Tubach. Off-label use of the expensive orphan drug eculizumab in France 2009–2013 and the impact of literature: focus on the transplantation field. European Journal of Clinical Pharmacology 2016; 72(6) doi: 10.1007/s00228-016-2027-z
16
Maurizio Salvadori, Giuseppina Rosso, Elisabetta Bertoni. Complement Involvement in Renal Transplantation. EMJ Nephrology 2015;  doi: 10.33590/emjnephrol/10313449
17
Jiang Qiu, Yehui Chen, Gang Huang, Zhi Zhang, Lizhong Chen, Ning Na. Transforming growth factor‐β activated long non‐coding RNA ATB plays an important role in acute rejection of renal allografts and may impacts the postoperative pharmaceutical immunosuppression therapy. Nephrology 2017; 22(10) doi: 10.1111/nep.12851
18
Xiao-Hua Yu, Wen-Yi Deng, Hong-Tao Jiang, Tao Li, Yi Wang. Kidney xenotransplantation: Recent progress in preclinical research. Clinica Chimica Acta 2021; 514 doi: 10.1016/j.cca.2020.11.028
19
Daniel Baron, Magali Giral, Sophie Brouard. Personalized Immunosuppression in Transplantation. 2016;  doi: 10.1016/B978-0-12-800885-0.00008-4
20
Oleg O. Rummo, Mario Carmellini, Lionel Rostaing, Rainer Oberbauer, Maarten H. L. Christiaans, Christiane Mousson, Robert M. Langer, Franco Citterio, Bernard Charpentier, Malcolm Brown, Gbenga Kazeem, Frank Lehner. ADHERE: randomized controlled trial comparing renal function inde novokidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimus. Transplant International 2017; 30(1) doi: 10.1111/tri.12878
21
B. Wilde, O. Witzke, T. Feldkamp. Biologika als Immunsuppressiva bei Nierentransplantation. Der Nephrologe 2014; 9(3) doi: 10.1007/s11560-014-0862-4
22
Arun K. Ghosh, Samuel Rodriguez. An enantioselective synthesis of the C3–C21 segment of the macrolide immunosuppressive agent FR252921. Tetrahedron Letters 2016; 57(26) doi: 10.1016/j.tetlet.2016.05.067
23
Lisa C. Martial, Bart A. W. Jacobs, Elisabeth A. M. Cornelissen, Anton F. J. de Haan, Birgit C. P. Koch, David M. Burger, Rob E. Aarnoutse, Michiel F. Schreuder, Roger J.M. Brüggemann. Pharmacokinetics and target attainment of mycophenolate in pediatric renal transplant patients. Pediatric Transplantation 2016; 20(4) doi: 10.1111/petr.12695
24
Angela C Webster, Sunny Wu, Krishna Tallapragada, Min Young Park, Jeremy R Chapman, Sue J Carr. Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients. Cochrane Database of Systematic Reviews 2017; 2017(7) doi: 10.1002/14651858.CD004756.pub4
25
Job C. Tharappel, Curtis E. Bower, Jennifer Whittington Harris, Sandeep K. Ramineni, David A. Puleo, J. Scott Roth. Doxycycline administration improves fascial interface in hernia repair. Journal of Surgical Research 2014; 190(2) doi: 10.1016/j.jss.2014.05.013
26
Xishao Xie, Yan Jiang, Xiuxiu Lai, Shilong Xiang, Zhangfei Shou, Jianghua Chen. mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis. BMC Nephrology 2015; 16(1) doi: 10.1186/s12882-015-0078-5
27
Majda Sahman, Snezana Mugosa, Nemanja Rancic. Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study. Frontiers in Public Health 2021; 9 doi: 10.3389/fpubh.2021.671316
28
Clemens Scheinecker. Blockade of co-stimulation in chronic inflammatory diseases. Wiener Medizinische Wochenschrift 2015; 165(1-2) doi: 10.1007/s10354-014-0313-x
29
Malte Kölling, George Haddad, Urs Wegmann, Andreas Kistler, Andrea Bosakova, Harald Seeger, Kerstin Hübel, Hermann Haller, Thomas Mueller, Rudolf P Wüthrich, Johan M Lorenzen. Circular RNAs in Urine of Kidney Transplant Patients with Acute T Cell-Mediated Allograft Rejection. Clinical Chemistry 2019; 65(10) doi: 10.1373/clinchem.2019.305854
30
Chen-Liang Chou. Braddom's Rehabilitation Care: A Clinical Handbook. 2018;  doi: 10.1016/B978-0-323-47904-2.00028-3
31
Amitava Dasgupta. Personalized Immunosuppression in Transplantation. 2016;  doi: 10.1016/B978-0-12-800885-0.00002-3
32
Martin Wagner, Amy K Earley, Angela C Webster, Christopher H Schmid, Ethan M Balk, Katrin Uhlig. Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients. Cochrane Database of Systematic Reviews 2015; 2015(12) doi: 10.1002/14651858.CD007746.pub2
33
E. Ono, A.M. dos Santos, P.O. Viana, M.I.S. Dinelli, N. Sass, L. De Oliveira, A.L. Goulart, M.I. de Moraes-Pinto. Immunophenotypic Profile and Increased Risk of Hospital Admission for Infection in Infants Born to Female Kidney Transplant Recipients. American Journal of Transplantation 2015; 15(6) doi: 10.1111/ajt.13143
34
Elizabeth G. Ingulli, Stephen I. Alexander, David M. Briscoe. Pediatric Nephrology. 2016;  doi: 10.1007/978-3-662-43596-0_64
35
Veruschka Albert, Gerhard Piendl, Dali Yousseff, Hedwig Lammert, Michael Hummel, Olaf Ortmann, Wolfgang Jagla, Andreas Gaumann, Anja K. Wege, Gero Brockhoff. Protein kinase C targeting of luminal (T-47D), luminal/HER2-positive (BT474), and triple negative (HCC1806) breast cancer cells in-vitro with AEB071 (Sotrastaurin) is efficient but mediated by subtype specific molecular effects. Archives of Gynecology and Obstetrics 2022; 306(4) doi: 10.1007/s00404-022-06434-2
36
Elizabeth Ingulli, Stephen I. Alexander, David M. Briscoe. Pediatric Nephrology. 2015;  doi: 10.1007/978-3-642-27843-3_64-1
37
Malgorzata Kloc, Marta Halasa, Souhail A. Thabet, Jarek Wosik, Ahmed Uosef, Arijita Subuddhi, Rafik Mark Ghobrial. Cellular and Molecular Mechanisms of Chronic Rejection in Organ Transplantation. Results and Problems in Cell Differentiation 2026; 77 doi: 10.1007/978-3-032-07686-1_6
38
Johan M Lorenzen, Celina Schauerte, Malte Kölling, Anika Hübner, Monika Knapp, Hermann Haller, Thomas Thum. Long Noncoding RNAs in Urine Are Detectable and May Enable Early Detection of Acute T Cell–Mediated Rejection of Renal Allografts. Clinical Chemistry 2015; 61(12) doi: 10.1373/clinchem.2015.243600